It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older.
originally posted by: Vasa Croe
So....from another thread I posted on. This is the full list of FDA licensed vaccines. Of note is the absence of any covid vaccines.
FDA Licensed Vaccine List
Now Pfizer applied for it May 7. It has still not gotten any approval or licensing for the manufacturer. This is why they are not allowed to advertise for it and why we haven't seen any vaccine manufacturer made commercials.
Here is the Pfizer announcement from May 7.
Pfizer presser
The important part:
The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older.
Bold is mine.
So.....not on the list and still not approved nor licensed....seems there is some need for concern in my mind.
I believe Moderna finally applied as well, but also has not been approved or licensed.
originally posted by: OccamsRazor04
a reply to: Vasa Croe
None of them will be until 2022 at the earliest. The process usually takes years after application, and in this case the FDA has made them a 'priority review' which will take ~6 months. So why would a few months be 'concerning'?
originally posted by: putnam6
originally posted by: Vasa Croe
So....from another thread I posted on. This is the full list of FDA licensed vaccines. Of note is the absence of any covid vaccines.
FDA Licensed Vaccine List
Now Pfizer applied for it May 7. It has still not gotten any approval or licensing for the manufacturer. This is why they are not allowed to advertise for it and why we haven't seen any vaccine manufacturer made commercials.
Here is the Pfizer announcement from May 7.
Pfizer presser
The important part:
The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older.
Bold is mine.
So.....not on the list and still not approved nor licensed....seems there is some need for concern in my mind.
I believe Moderna finally applied as well, but also has not been approved or licensed.
I suspect this is why there is another concentrated push for people to get vaccinated. They cant operate under emergency approval forever. Sooner or later the FDA will say that's enough of this crap, we are no longer under a national emergency
noun A preparation of a weakened or killed pathogen, such as a bacterium or virus, or of a portion of the pathogen's structure that upon administration to an individual stimulates antibody production or cellular immunity against the pathogen but is incapable of causing severe infection.
...that upon administration to an individual stimulates antibody production or cellular immunity against the pathogen
... but is incapable of causing severe infection.
TextThe Pfizer-BioNTech COVID-19 Vaccine is currently available in the U.S. under an Emergency Use Authorization (EUA) granted by the FDA on December 11, 2020. Since then, the companies have delivered more than 170 million doses of the vaccine across the U.S. Submission of a BLA, which requires longer-term follow-up data for acceptance and approval, is the next step in the rigorous FDA review process.
“We are proud of the tremendous progress we’ve made since December in delivering vaccines to millions of Americans, in collaboration with the U.S. Government,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “We look forward to working with the FDA to complete this rolling submission and support their review, with the goal of securing full regulatory approval of the vaccine in the coming months.”
“Following the successful delivery of more than 170 million doses to the U.S. population in just a few months, the BLA submission is an important cornerstone of achieving long-term herd immunity and containing COVID-19 in the future,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech. “We are pleased to work with U.S. regulators to seek approval of our COVID-19 vaccine based on our pivotal Phase 3 trial and follow-up data.”
Pfizer and BioNTech initiated the BLA by submitting the nonclinical and clinical data needed to support licensure of the COVID-19 vaccine for use in individuals 16 years of age and older. This includes the most recent analyses from the pivotal Phase 3 clinical trial, where the vaccine’s efficacy and favorable safety profile were observed up to six months after the second dose. The companies will submit the required manufacturing and facility data for licensure in the coming weeks to complete the BLA.
Pfizer and BioNTech also have submitted an application to expand the current EUA for their COVID-19 vaccine to include individuals 12 to 15 years of age. The companies intend to submit a supplemental BLA to support licensure of the vaccine in this age group once the required data six months after the second vaccine dose are available.
The Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech proprietary mRNA technology, was developed by both BioNTech and Pfizer.
"AstraZeneca COVID-19 Vaccine and COVISHIELD (the version of the AstraZeneca COVID-19 Vaccine manufactured by the Serum Institute of India) are now contraindicated in individuals who have previously experienced episodes of CLS."
"Healthcare professionals should be alert to the signs and symptoms of CLS. CLS is a very rare disorder, which is frequently life threatening, characterised by a dysfunctional inflammatory response, endothelial dysfunction, extravasation of fluid from the vascular space to the interstitial space leading to shock, hemoconcentration, hypoalbuminemia and consequent organ failure. Patients may present with a rapid swelling of the arms and legs, sudden weight gain and have symptoms associated with low blood pressure/shock."